| Triggering and augmentation mechanisms, granule pools, and biphasic insulin secretion TK Bratanova-Tochkova, H Cheng, S Daniel, S Gunawardana, YJ Liu, ... Diabetes 51 (suppl_1), S83-S90, 2002 | 435 | 2002 |
| Update 2020: management of non-small cell lung cancer M Alexander, SY Kim, H Cheng Lung 198 (6), 897-907, 2020 | 413 | 2020 |
| Next-generation sequencing of pulmonary sarcomatoid carcinoma reveals high frequency of actionable MET gene mutations X Liu, Y Jia, MB Stoopler, Y Shen, H Cheng, J Chen, M Mansukhani, ... J Clin Oncol 34 (8), 794-802, 2016 | 354 | 2016 |
| Leptomeningeal metastases in non-small-cell lung cancer H Cheng, R Perez-Soler The Lancet Oncology 19 (1), e43-e55, 2018 | 233 | 2018 |
| Key role for AMP-activated protein kinase in the ventromedial hypothalamus in regulating counterregulatory hormone responses to acute hypoglycemia RJ McCrimmon, M Shaw, X Fan, H Cheng, Y Ding, MC Vella, L Zhou, ... Diabetes 57 (2), 444-450, 2008 | 196 | 2008 |
| Targeting the PI3K/AKT/mTOR pathway: potential for lung cancer treatment H Cheng, M Shcherba, G Pendurti, Y Liang, B Piperdi, R Perez-Soler Lung cancer management 3 (1), 67-75, 2014 | 142 | 2014 |
| Activation of AMP-activated protein kinase within the ventromedial hypothalamus amplifies counterregulatory hormone responses in rats with defective counterregulation RJ McCrimmon, X Fan, H Cheng, E McNay, O Chan, M Shaw, Y Ding, ... Diabetes 55 (6), 1755-1760, 2006 | 128 | 2006 |
| Increased GABAergic tone in the ventromedial hypothalamus contributes to suppression of counterregulatory reponses after antecedent hypoglycemia O Chan, H Cheng, R Herzog, D Czyzyk, W Zhu, A Wang, RJ McCrimmon, ... Diabetes 57 (5), 1363-1370, 2008 | 117 | 2008 |
| RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 Inhibitors H Cheng, Y Zou, JS Ross, K Wang, X Liu, B Halmos, SM Ali, H Liu, ... Cancer discovery 5 (12), 1262-1270, 2015 | 111 | 2015 |
| HHLA2, a new immune checkpoint member of the B7 family, is widely expressed in human lung cancer and associated with EGFR mutational status H Cheng, M Janakiram, A Borczuk, J Lin, W Qiu, H Liu, JM Chinai, ... Clinical Cancer Research 23 (3), 825-832, 2017 | 107 | 2017 |
| PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells H Cheng, Z Zhang, A Borczuk, CA Powell, AS Balajee, HB Lieberman, ... Carcinogenesis 34 (4), 739-749, 2013 | 106 | 2013 |
| Corticotrophin-releasing factor receptors within the ventromedial hypothalamus regulate hypoglycemia-induced hormonal counterregulation RJ McCrimmon, Z Song, H Cheng, EC McNay, C Weikart-Yeckel, X Fan, ... The Journal of clinical investigation 116 (6), 1723-1730, 2006 | 101 | 2006 |
| Functional genomics screen identifies YAP1 as a key determinant to enhance treatment sensitivity in lung cancer cells H Cheng, Z Zhang, R Rodriguez-Barrueco, A Borczuk, H Liu, J Yu, ... Oncotarget 7 (20), 28976, 2016 | 99 | 2016 |
| Immune checkpoint blockade in human cancer therapy: lung cancer and hematologic malignancies M Janakiram, V Pareek, H Cheng, DM Narasimhulu, X Zang Immunotherapy 8 (7), 809-819, 2016 | 77 | 2016 |
| Wide expression and significance of alternative immune checkpoint molecules, B7x and HHLA2, in PD-L1–negative human lung cancers H Cheng, A Borczuk, M Janakiram, X Ren, J Lin, A Assal, B Halmos, ... Clinical Cancer Research 24 (8), 1954-1964, 2018 | 76 | 2018 |
| Activation of the KATP channel-independent signaling pathway by the nonhydrolyzable analog of leucine, BCH YJ Liu, H Cheng, H Drought, MJ MacDonald, GWG Sharp, SG Straub American Journal of Physiology-Endocrinology and Metabolism 285 (2), E380-E389, 2003 | 75 | 2003 |
| Nanoparticle albumin bound-paclitaxel for treatment of advanced non-small cell lung cancer: an evaluation of the clinical evidence D Adrianzen Herrera, N Ashai, R Perez-Soler, H Cheng Expert opinion on pharmacotherapy 20 (1), 95-102, 2019 | 62 | 2019 |
| Hypothalamic AMP-activated protein kinase activation with AICAR amplifies counterregulatory responses to hypoglycemia in a rodent model of type 1 diabetes X Fan, Y Ding, S Brown, L Zhou, M Shaw, MC Vella, H Cheng, EC McNay, ... American Journal of Physiology-Regulatory, Integrative and Comparative …, 2009 | 58 | 2009 |
| Protein acylation in the inhibition of insulin secretion by norepinephrine, somatostatin, galanin, and PGE2 H Cheng, SG Straub, GWG Sharp American Journal of Physiology-Endocrinology and Metabolism 285 (2), E287-E294, 2003 | 58 | 2003 |
| Update 2021: management of small cell lung cancer S Tariq, SY Kim, J Monteiro de Oliveira Novaes, H Cheng Lung, 1-9, 2021 | 50 | 2021 |
